| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.98e-06 | 37 | 136 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.70e-06 | 38 | 136 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.90e-05 | 11 | 136 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 1.06e-04 | 14 | 136 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 1.71e-04 | 76 | 136 | 5 | GO:0098631 | |
| GeneOntologyMolecularFunction | myosin binding | 2.89e-04 | 85 | 136 | 5 | GO:0017022 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.76e-04 | 21 | 136 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 4.54e-04 | 5 | 136 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 6.78e-04 | 6 | 136 | 2 | GO:0000048 | |
| GeneOntologyMolecularFunction | keratin filament binding | 6.78e-04 | 6 | 136 | 2 | GO:1990254 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 6.78e-04 | 6 | 136 | 2 | GO:0002951 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 7.95e-04 | 61 | 136 | 4 | GO:0098632 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 8.94e-04 | 28 | 136 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 9.46e-04 | 7 | 136 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.21e-03 | 31 | 136 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 1.26e-03 | 8 | 136 | 2 | GO:0103068 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.33e-03 | 32 | 136 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.61e-03 | 9 | 136 | 2 | GO:0036374 | |
| GeneOntologyBiologicalProcess | axon guidance | SEMA6B CNTN4 NTRK1 L1CAM EDNRA CNTN6 MAPK8IP3 SEMA5B LRP1 IGSF9 ROBO3 | 2.84e-06 | 285 | 135 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | SEMA6B CNTN4 NTRK1 L1CAM EDNRA CNTN6 MAPK8IP3 SEMA5B LRP1 IGSF9 ROBO3 | 2.94e-06 | 286 | 135 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | dendrite self-avoidance | 5.00e-06 | 18 | 135 | 4 | GO:0070593 | |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA6B CNTN4 FLNA NTRK1 L1CAM SARM1 OBSL1 TSC2 SPAG9 ADGRV1 CSMD3 EDNRA CNTN6 MAPK8IP3 SLC12A5 SEMA5B AGER LRP1 LRP6 IGSF9 DMD ROBO3 INPP5J | 9.69e-06 | 1285 | 135 | 23 | GO:0031175 |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 2.00e-05 | 25 | 135 | 4 | GO:0009070 | |
| GeneOntologyBiologicalProcess | neuron recognition | 4.20e-05 | 59 | 135 | 5 | GO:0008038 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 6.99e-05 | 34 | 135 | 4 | GO:0043043 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SEMA6B CNTN4 NTRK1 L1CAM SARM1 OBSL1 TSC2 SPAG9 EDNRA CNTN6 MAPK8IP3 SEMA5B LRP1 IGSF9 DMD ROBO3 | 7.23e-05 | 802 | 135 | 16 | GO:0048812 |
| GeneOntologyBiologicalProcess | neuron development | SEMA6B CNTN4 FLNA NTRK1 L1CAM SARM1 OBSL1 TSC2 SPAG9 ADGRV1 CSMD3 EDNRA CNTN6 MAPK8IP3 SLC12A5 SEMA5B AGER LRP1 LRP6 IGSF9 DMD ROBO3 INPP5J | 7.41e-05 | 1463 | 135 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | DNA integration | 7.47e-05 | 13 | 135 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SEMA6B CNTN4 NTRK1 L1CAM SARM1 OBSL1 TSC2 SPAG9 EDNRA CNTN6 MAPK8IP3 SEMA5B LRP1 IGSF9 DMD ROBO3 | 9.24e-05 | 819 | 135 | 16 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SEMA6B CNTN4 NTRK1 L1CAM SARM1 OBSL1 TSC2 SPAG9 EDNRA CNTN6 MAPK8IP3 SEMA5B LRP1 IGSF9 DMD ROBO3 | 1.02e-04 | 826 | 135 | 16 | GO:0048858 |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 1.44e-04 | 16 | 135 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 1.78e-04 | 43 | 135 | 4 | GO:0009069 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 2.27e-04 | 84 | 135 | 5 | GO:0006518 | |
| GeneOntologyBiologicalProcess | establishment of blood-brain barrier | 2.46e-04 | 19 | 135 | 3 | GO:0060856 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA6B CNTN4 FLNA NTRK1 L1CAM SARM1 OBSL1 TSC2 SPAG9 EDNRA CNTN6 MAPK8IP3 SEMA5B NBEAL2 LRP1 LRP6 IGSF9 DMD ROBO3 | 2.89e-04 | 1194 | 135 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | axon development | SEMA6B CNTN4 FLNA NTRK1 L1CAM TSC2 EDNRA CNTN6 MAPK8IP3 SEMA5B LRP1 IGSF9 ROBO3 | 3.08e-04 | 642 | 135 | 13 | GO:0061564 |
| GeneOntologyCellularComponent | axon | CNTN4 FLNA TRPM7 NTRK1 L1CAM SARM1 GRIA1 TSC2 CNTN6 MAPK8IP3 AGER SBF2 LRP1 IGSF9 DMD ROBO3 ATP2B3 INPP5J | 1.94e-05 | 891 | 136 | 18 | GO:0030424 |
| Domain | Ig_I-set | CNTN4 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 8.47e-08 | 190 | 129 | 11 | IPR013098 |
| Domain | I-set | CNTN4 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 8.47e-08 | 190 | 129 | 11 | PF07679 |
| Domain | IGc2 | CNTN4 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 7.16e-07 | 235 | 129 | 11 | SM00408 |
| Domain | Ig_sub2 | CNTN4 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 7.16e-07 | 235 | 129 | 11 | IPR003598 |
| Domain | Calx_beta | 2.62e-05 | 9 | 129 | 3 | IPR003644 | |
| Domain | Calx-beta | 2.62e-05 | 9 | 129 | 3 | PF03160 | |
| Domain | IG | CNTN4 NTRK1 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 3.57e-05 | 421 | 129 | 12 | SM00409 |
| Domain | Ig_sub | CNTN4 NTRK1 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 3.57e-05 | 421 | 129 | 12 | IPR003599 |
| Domain | JIP_LZII | 4.73e-05 | 2 | 129 | 2 | IPR032486 | |
| Domain | LRP5/6 | 4.73e-05 | 2 | 129 | 2 | IPR017049 | |
| Domain | JIP_LZII | 4.73e-05 | 2 | 129 | 2 | PF16471 | |
| Domain | Ldl_recept_b | 1.11e-04 | 14 | 129 | 3 | PF00058 | |
| Domain | LDLRB | 1.11e-04 | 14 | 129 | 3 | PS51120 | |
| Domain | fn3 | 1.34e-04 | 162 | 129 | 7 | PF00041 | |
| Domain | LY | 1.38e-04 | 15 | 129 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.38e-04 | 15 | 129 | 3 | IPR000033 | |
| Domain | IG_LIKE | CNTN4 NTRK1 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 1.54e-04 | 491 | 129 | 12 | PS50835 |
| Domain | Ig-like_dom | CNTN4 NTRK1 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 ROBO3 | 1.93e-04 | 503 | 129 | 12 | IPR007110 |
| Domain | - | CNTN4 FLNA NTRK1 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 EXOC2 ROBO3 | 1.99e-04 | 663 | 129 | 14 | 2.60.40.10 |
| Domain | EGF | 2.42e-04 | 126 | 129 | 6 | PF00008 | |
| Domain | JNK/Rab-associated_protein-1_N | 2.81e-04 | 4 | 129 | 2 | IPR019143 | |
| Domain | TRPM_tetra | 2.81e-04 | 4 | 129 | 2 | PF16519 | |
| Domain | Jnk-SapK_ap_N | 2.81e-04 | 4 | 129 | 2 | PF09744 | |
| Domain | TRPM_tetra | 2.81e-04 | 4 | 129 | 2 | IPR032415 | |
| Domain | FN3 | 3.02e-04 | 185 | 129 | 7 | SM00060 | |
| Domain | ig | 3.55e-04 | 190 | 129 | 7 | PF00047 | |
| Domain | Immunoglobulin | 3.55e-04 | 190 | 129 | 7 | IPR013151 | |
| Domain | Ig-like_fold | CNTN4 FLNA NTRK1 L1CAM OBSL1 CNTN6 TYRO3 HMCN1 BSG AGER IGSF9 SIGLEC1 EXOC2 ROBO3 | 3.77e-04 | 706 | 129 | 14 | IPR013783 |
| Domain | RH2 | 4.67e-04 | 5 | 129 | 2 | PS51777 | |
| Domain | RH1 | 4.67e-04 | 5 | 129 | 2 | PS51776 | |
| Domain | FN3 | 4.69e-04 | 199 | 129 | 7 | PS50853 | |
| Domain | - | SEMA6B FBXW10B GRWD1 SPAG9 MAPK8IP3 SEMA5B NBEAL2 WDR24 DCAF7 | 5.14e-04 | 333 | 129 | 9 | 2.130.10.10 |
| Domain | ACTININ_2 | 5.15e-04 | 23 | 129 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.15e-04 | 23 | 129 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.15e-04 | 23 | 129 | 3 | IPR001589 | |
| Domain | WD40/YVTN_repeat-like_dom | SEMA6B FBXW10B GRWD1 SPAG9 MAPK8IP3 SEMA5B NBEAL2 WDR24 DCAF7 | 5.37e-04 | 335 | 129 | 9 | IPR015943 |
| Domain | JmjC | 5.86e-04 | 24 | 129 | 3 | PF02373 | |
| Domain | FN3_dom | 6.27e-04 | 209 | 129 | 7 | IPR003961 | |
| Domain | Alpha_kinase | 6.97e-04 | 6 | 129 | 2 | PF02816 | |
| Domain | MHCK_EF2_kinase | 6.97e-04 | 6 | 129 | 2 | IPR004166 | |
| Domain | ALPHA_KINASE | 6.97e-04 | 6 | 129 | 2 | PS51158 | |
| Domain | Alpha_kinase | 6.97e-04 | 6 | 129 | 2 | SM00811 | |
| Domain | GGT_peptidase | 9.72e-04 | 7 | 129 | 2 | IPR000101 | |
| Domain | KOW | 9.72e-04 | 7 | 129 | 2 | SM00739 | |
| Domain | G_glu_transpept | 9.72e-04 | 7 | 129 | 2 | PF01019 | |
| Domain | G_GLU_TRANSPEPTIDASE | 9.72e-04 | 7 | 129 | 2 | PS00462 | |
| Domain | EGF | 1.24e-03 | 235 | 129 | 7 | SM00181 | |
| Domain | Calx_beta | 1.29e-03 | 8 | 129 | 2 | SM00237 | |
| Domain | JMJC | 1.38e-03 | 32 | 129 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.38e-03 | 32 | 129 | 3 | IPR003347 | |
| Domain | CH | 1.40e-03 | 70 | 129 | 4 | PF00307 | |
| Domain | - | 1.48e-03 | 71 | 129 | 4 | 1.10.418.10 | |
| Domain | JmjC | 1.51e-03 | 33 | 129 | 3 | SM00558 | |
| Domain | CH | 1.64e-03 | 73 | 129 | 4 | PS50021 | |
| Domain | EGF-like_Ca-bd_dom | 1.70e-03 | 124 | 129 | 5 | IPR001881 | |
| Domain | EGF-like_dom | 1.73e-03 | 249 | 129 | 7 | IPR000742 | |
| Domain | CH-domain | 1.81e-03 | 75 | 129 | 4 | IPR001715 | |
| Domain | - | 2.45e-03 | 39 | 129 | 3 | 2.120.10.30 | |
| Domain | KOW | 2.50e-03 | 11 | 129 | 2 | IPR005824 | |
| Domain | KOW | 2.50e-03 | 11 | 129 | 2 | PF00467 | |
| Domain | NA_SOLUT_SYMP_1 | 2.50e-03 | 11 | 129 | 2 | PS00456 | |
| Domain | LDLR_class-A_CS | 2.64e-03 | 40 | 129 | 3 | IPR023415 | |
| Domain | EGF_CA | 2.98e-03 | 86 | 129 | 4 | PF07645 | |
| Domain | EGF_dom | 2.99e-03 | 12 | 129 | 2 | IPR024731 | |
| Domain | SSF | 2.99e-03 | 12 | 129 | 2 | PF00474 | |
| Domain | EGF_3 | 2.99e-03 | 12 | 129 | 2 | PF12947 | |
| Domain | NA_SOLUT_SYMP_2 | 2.99e-03 | 12 | 129 | 2 | PS00457 | |
| Domain | Na/solute_symporter | 2.99e-03 | 12 | 129 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 2.99e-03 | 12 | 129 | 2 | PS50283 | |
| Domain | Ldl_recept_a | 3.70e-03 | 45 | 129 | 3 | PF00057 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.93e-03 | 46 | 129 | 3 | IPR011042 | |
| Domain | - | 3.93e-03 | 46 | 129 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 4.44e-03 | 48 | 129 | 3 | PS01209 | |
| Domain | WD40_repeat_dom | 4.60e-03 | 297 | 129 | 7 | IPR017986 | |
| Domain | LDrepeatLR_classA_rpt | 4.70e-03 | 49 | 129 | 3 | IPR002172 | |
| Domain | LDLa | 4.70e-03 | 49 | 129 | 3 | SM00192 | |
| Domain | LDLRA_2 | 4.70e-03 | 49 | 129 | 3 | PS50068 | |
| Domain | EGF_CA | 4.93e-03 | 99 | 129 | 4 | PS01187 | |
| Domain | EGF_3 | 5.86e-03 | 235 | 129 | 6 | PS50026 | |
| Domain | Translation_prot_SH3-like | 6.02e-03 | 17 | 129 | 2 | IPR008991 | |
| Domain | Rib_L2_dom2 | 6.74e-03 | 18 | 129 | 2 | IPR014722 | |
| Domain | - | 6.74e-03 | 18 | 129 | 2 | 2.30.30.30 | |
| Pubmed | 1.89e-08 | 162 | 138 | 9 | 25826454 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6B FLNA EPPK1 L1CAM TSC2 KDM6B FAM83H MAPK8IP3 SEPHS2 FASN NBEAL2 SBF2 LRP5 SNAPC4 MBD5 TTC38 PKN3 WDR24 HR | 8.52e-08 | 1105 | 138 | 19 | 35748872 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.08e-07 | 5 | 138 | 3 | 12629516 | |
| Pubmed | Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage. | 1.21e-06 | 6 | 138 | 3 | 30955887 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 2.86e-06 | 219 | 138 | 8 | 31353912 | |
| Pubmed | 7.62e-06 | 117 | 138 | 6 | 17145500 | ||
| Pubmed | 9.85e-06 | 11 | 138 | 3 | 24639464 | ||
| Pubmed | Dynamic expression of the TRPM subgroup of ion channels in developing mouse sensory neurons. | 1.31e-05 | 12 | 138 | 3 | 19850157 | |
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 1.31e-05 | 12 | 138 | 3 | 16701205 | |
| Pubmed | 1.31e-05 | 12 | 138 | 3 | 14557543 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 SLC25A24 FLNA GRWD1 BAZ1B APOB IDH3A PGK1 SLC5A2 EFTUD2 FASN CCT5 BSG SUPT5H SEC23IP DLD ATP2B3 DCAF7 | 1.46e-05 | 1425 | 138 | 18 | 30948266 |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34294193 | ||
| Pubmed | Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. | 1.56e-05 | 2 | 138 | 2 | 16636202 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20668298 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 29500156 | ||
| Pubmed | Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6. | 1.56e-05 | 2 | 138 | 2 | 21887268 | |
| Pubmed | JMJD3 and UTX determine fidelity and lineage specification of human neural progenitor cells. | 1.56e-05 | 2 | 138 | 2 | 31959746 | |
| Pubmed | PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors. | 1.56e-05 | 2 | 138 | 2 | 33136328 | |
| Pubmed | LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. | 1.56e-05 | 2 | 138 | 2 | 15084453 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24858416 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9403059 | ||
| Pubmed | Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. | 1.56e-05 | 2 | 138 | 2 | 25132549 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19149903 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33164872 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18365021 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 29912990 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33788575 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 14976260 | ||
| Pubmed | Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma. | 1.56e-05 | 2 | 138 | 2 | 28197626 | |
| Pubmed | LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis. | 1.56e-05 | 2 | 138 | 2 | 25902418 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26820600 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21602712 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30474181 | ||
| Pubmed | Inhibition of KDM6 activity during murine ESC differentiation induces DNA damage. | 1.56e-05 | 2 | 138 | 2 | 26759175 | |
| Pubmed | Histone H3 Lysine 27 demethylases Jmjd3 and Utx are required for T-cell differentiation. | 1.56e-05 | 2 | 138 | 2 | 26328764 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 36552732 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25783012 | ||
| Pubmed | Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts. | 1.56e-05 | 2 | 138 | 2 | 19147944 | |
| Pubmed | Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. | 1.56e-05 | 2 | 138 | 2 | 15537447 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 17335347 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25692682 | ||
| Pubmed | Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX. | 1.56e-05 | 2 | 138 | 2 | 27151432 | |
| Pubmed | Inhibition of neuronal pentraxin 2 relieved epileptic seizure via reducing GluA1 phosphorylation. | 1.56e-05 | 2 | 138 | 2 | 38597235 | |
| Pubmed | The TRPM6 kinase domain determines the Mg·ATP sensitivity of TRPM7/M6 heteromeric ion channels. | 1.56e-05 | 2 | 138 | 2 | 24385424 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18648652 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25101834 | ||
| Pubmed | The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. | 1.56e-05 | 2 | 138 | 2 | 19503830 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 37202775 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20926594 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23508966 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 16355283 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28425175 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 23228658 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31690808 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 32929331 | ||
| Pubmed | The channel kinases TRPM6 and TRPM7 are functionally nonredundant. | 1.56e-05 | 2 | 138 | 2 | 16150690 | |
| Pubmed | Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. | 1.56e-05 | 2 | 138 | 2 | 18350154 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28821869 | ||
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 1.56e-05 | 2 | 138 | 2 | 26031789 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22589717 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18301276 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18675813 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 33118644 | ||
| Pubmed | Identification of genes showing differential expression in anorexia mutant mouse. | 1.56e-05 | 2 | 138 | 2 | 12802202 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25500815 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18493104 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30389724 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 28220887 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9060628 | ||
| Pubmed | A homozygous mutation p.Arg2167Trp in FREM2 causes isolated cryptophthalmos. | 1.56e-05 | 2 | 138 | 2 | 29688405 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30668923 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.56e-05 | 2 | 138 | 2 | 9460924 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22433869 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30281092 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 18192217 | ||
| Pubmed | Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. | 1.56e-05 | 2 | 138 | 2 | 25802278 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30626691 | ||
| Pubmed | Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. | 1.56e-05 | 2 | 138 | 2 | 2919177 | |
| Pubmed | Kdm6b regulates context-dependent hematopoietic stem cell self-renewal and leukemogenesis. | 1.56e-05 | 2 | 138 | 2 | 30936419 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21245294 | ||
| Pubmed | Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin. | 1.56e-05 | 2 | 138 | 2 | 26563869 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 22907667 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 26179995 | ||
| Pubmed | Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis. | 1.56e-05 | 2 | 138 | 2 | 16075242 | |
| Pubmed | Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. | 1.56e-05 | 2 | 138 | 2 | 21209387 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27384759 | ||
| Pubmed | Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation. | 1.56e-05 | 2 | 138 | 2 | 34880105 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 34326388 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 37967646 | ||
| Pubmed | Distinct roles of LRP5 and LRP6 in Wnt signaling regulation in the retina. | 1.56e-05 | 2 | 138 | 2 | 33545636 | |
| Pubmed | TRPM6 is Essential for Magnesium Uptake and Epithelial Cell Function in the Colon. | 1.56e-05 | 2 | 138 | 2 | 29912157 | |
| Pubmed | Magnesium and its transporters in cancer: a novel paradigm in tumour development. | 1.56e-05 | 2 | 138 | 2 | 22671428 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 25552720 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 12579474 | ||
| Pubmed | Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. | 1.56e-05 | 2 | 138 | 2 | 18003914 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 20875900 | ||
| Pubmed | Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy. | 1.56e-05 | 2 | 138 | 2 | 30085099 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27983522 | ||
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 1.70e-05 | 13 | 138 | 3 | 24559674 | |
| Pubmed | Genetic mapping of the mouse X chromosome in the region homologous to human Xq27-Xq28. | 2.15e-05 | 14 | 138 | 3 | 1674728 | |
| Cytoband | Xq28 | 1.94e-04 | 176 | 137 | 5 | Xq28 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXq28 | 4.66e-04 | 213 | 137 | 5 | chrXq28 | |
| Cytoband | 15q21 | 4.78e-04 | 11 | 137 | 2 | 15q21 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.01e-08 | 161 | 93 | 10 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 6.84e-06 | 193 | 93 | 8 | 594 | |
| GeneFamily | Low density lipoprotein receptors | 3.63e-05 | 13 | 93 | 3 | 634 | |
| GeneFamily | Fibronectin type III domain containing | 1.77e-04 | 160 | 93 | 6 | 555 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 1.97e-03 | 13 | 93 | 2 | 564 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-08 | 184 | 133 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-08 | 184 | 133 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-08 | 184 | 133 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.96e-06 | 194 | 133 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 196 | 133 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-06 | 196 | 133 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-06 | 200 | 133 | 7 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-06 | 142 | 133 | 6 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-06 | 142 | 133 | 6 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LA-06._Ventricular_Cardiomyocyte_II|LA / Chamber and Cluster_Paper | 8.37e-06 | 92 | 133 | 5 | fad2e02ae858e3a9bbe51ad1c689f7e31d11ce0e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.01e-06 | 161 | 133 | 6 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.34e-06 | 162 | 133 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 165 | 133 | 6 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.27e-05 | 171 | 133 | 6 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.31e-05 | 172 | 133 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-05 | 173 | 133 | 6 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 174 | 133 | 6 | edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-I_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 174 | 133 | 6 | 65539f69100db0b7d90b1b39ee15ab8281f86461 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 177 | 133 | 6 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 181 | 133 | 6 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-05 | 181 | 133 | 6 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-05 | 183 | 133 | 6 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | Healthy-HSPC|World / disease group, cell group and cell class | 2.11e-05 | 187 | 133 | 6 | 8cd9e5499e5c2b2321ecbcf780df37fe0f165ac9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 133 | 6 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 133 | 6 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 133 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 188 | 133 | 6 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-05 | 188 | 133 | 6 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 188 | 133 | 6 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 190 | 133 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 190 | 133 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 192 | 133 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-05 | 192 | 133 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 193 | 133 | 6 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.52e-05 | 193 | 133 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 193 | 133 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 195 | 133 | 6 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 195 | 133 | 6 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 195 | 133 | 6 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | P03-Mesenchymal|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.67e-05 | 195 | 133 | 6 | 6180309c6ae278b996fd98c57461cbc129c028ba | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.82e-05 | 197 | 133 | 6 | 4f8f23b1ef2eae9d300bd2c1a5cb7ef0163858a1 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Basal_3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.82e-05 | 197 | 133 | 6 | 2cff37f9d33951840a8f52ccbba6ca1a4bbe3ad9 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.82e-05 | 197 | 133 | 6 | 0f37afad46b94c748a149d9ee681472d7a3e6937 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Mucous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-05 | 198 | 133 | 6 | 2ae9564da9913510141994262f3739eb095e0a68 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 2.90e-05 | 198 | 133 | 6 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 2.90e-05 | 198 | 133 | 6 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-05 | 199 | 133 | 6 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 200 | 133 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.07e-05 | 200 | 133 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 200 | 133 | 6 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-05 | 200 | 133 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.56e-05 | 141 | 133 | 5 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.56e-05 | 141 | 133 | 5 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 142 | 133 | 5 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-05 | 145 | 133 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 156 | 133 | 5 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 156 | 133 | 5 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-04 | 156 | 133 | 5 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.09e-04 | 157 | 133 | 5 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-04 | 157 | 133 | 5 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.23e-04 | 161 | 133 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.30e-04 | 163 | 133 | 5 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | LA-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.40e-04 | 88 | 133 | 4 | 7232b13a9788f89600411222c0d93bdc3788816f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 169 | 133 | 5 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | mild_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 1.58e-04 | 170 | 133 | 5 | 85c476e0bc496445e868a88849960598d97bdea2 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.62e-04 | 171 | 133 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.62e-04 | 171 | 133 | 5 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 171 | 133 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.67e-04 | 172 | 133 | 5 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 173 | 133 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.76e-04 | 174 | 133 | 5 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.76e-04 | 174 | 133 | 5 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.76e-04 | 174 | 133 | 5 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.76e-04 | 174 | 133 | 5 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.81e-04 | 175 | 133 | 5 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 175 | 133 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-04 | 176 | 133 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-04 | 177 | 133 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 177 | 133 | 5 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 177 | 133 | 5 | f6b9d91d46830d0d207b0abd4ee5a4942fd99774 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.96e-04 | 178 | 133 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-04 | 178 | 133 | 5 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 179 | 133 | 5 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 180 | 133 | 5 | a37cc885fe3f6cb9df69d43358064c83c18412e7 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 180 | 133 | 5 | 63a6d532b16b8b15c7c9102148d7297ee3afd641 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.06e-04 | 180 | 133 | 5 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 181 | 133 | 5 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 181 | 133 | 5 | f6629fa71bb94405f523f63a9264cacf6d15c5f4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 181 | 133 | 5 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-04 | 181 | 133 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-04 | 181 | 133 | 5 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.13e-04 | 98 | 133 | 4 | 7a62a77ca83153dacff4d02d6e32104227d0980d | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocye.Tnr.Pdgfa_(Pdgfa)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.13e-04 | 98 | 133 | 4 | 26250ea4171a0557a67505839cf79d3fe4d9d41a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.13e-04 | 98 | 133 | 4 | 42875d16ae9fcbaf988cd71be82568f2f862f2dd | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-04 | 182 | 133 | 5 | f231e86524b628e6e11ac33d5c34be99d454a92a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 183 | 133 | 5 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 183 | 133 | 5 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 183 | 133 | 5 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.28e-04 | 184 | 133 | 5 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-04 | 184 | 133 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| Drug | 5-(2-chlorophenyl)-2-furoic acid | 2.73e-07 | 47 | 130 | 6 | CID000784625 | |
| Drug | Methamphetamine | FLNA NPTX2 ACACB SARM1 OBSL1 BAZ1B COX10 GRIA1 SPAG9 IDH3A CUBN KDM6B PGK1 MAPK8IP3 OPRL1 FCGBP CCT5 SUPT5H LRP1 DLD DMD KDM6A PKN3 HR | 1.18e-06 | 1401 | 130 | 24 | ctd:D008694 |
| Disease | Marles Greenberg Persaud syndrome | 1.81e-05 | 2 | 126 | 2 | C1855425 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.57e-05 | 276 | 126 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | Congenital small ears | 2.84e-05 | 41 | 126 | 4 | C0152423 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.32e-05 | 148 | 126 | 6 | C0279702 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 6.51e-05 | 315 | 126 | 8 | EFO_0004612, EFO_0008591 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 1.08e-04 | 4 | 126 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | tuberous sclerosis (is_marker_for) | 1.08e-04 | 4 | 126 | 2 | DOID:13515 (is_marker_for) | |
| Disease | muscular disease (implicated_via_orthology) | 1.79e-04 | 5 | 126 | 2 | DOID:0080000 (implicated_via_orthology) | |
| Disease | Macrothrombocytopenia | 1.79e-04 | 5 | 126 | 2 | C2751260 | |
| Disease | Colorectal Carcinoma | CNTN4 TRPM7 APOB CUBN CSMD3 SLC12A5 CFAP77 LRP1 DMD KDM6A HR | 2.19e-04 | 702 | 126 | 11 | C0009402 |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.65e-04 | 206 | 126 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | Morphine Abuse | 3.75e-04 | 7 | 126 | 2 | C0600272 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 3.75e-04 | 7 | 126 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | Morphine Dependence | 3.75e-04 | 7 | 126 | 2 | C0026552 | |
| Disease | MASA syndrome (implicated_via_orthology) | 3.75e-04 | 7 | 126 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 4.72e-04 | 321 | 126 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | alcohol dependence (biomarker_via_orthology) | 4.98e-04 | 8 | 126 | 2 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 4.98e-04 | 8 | 126 | 2 | C0266294 | |
| Disease | calpastatin measurement | 4.98e-04 | 8 | 126 | 2 | EFO_0008065 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.14e-04 | 86 | 126 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 5.57e-04 | 330 | 126 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 6.34e-04 | 243 | 126 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | pulse pressure measurement | TRPM7 CELA2A KDM6B EDNRA OPRL1 SLC5A11 THBS2 FASN FAM13A SBF2 LRP1 LOXL4 ROBO3 MBD5 CMAHP | 8.95e-04 | 1392 | 126 | 15 | EFO_0005763 |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 1.07e-03 | 47 | 126 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.13e-03 | 106 | 126 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.16e-03 | 12 | 126 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.18e-03 | 274 | 126 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | cholesteryl ester 20:3 measurement | 1.21e-03 | 49 | 126 | 3 | EFO_0010347 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.29e-03 | 110 | 126 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.29e-03 | 110 | 126 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.29e-03 | 110 | 126 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | hair colour measurement | 1.33e-03 | 615 | 126 | 9 | EFO_0007822 | |
| Disease | pulmonary function measurement, FEV/FEC ratio | 1.52e-03 | 53 | 126 | 3 | EFO_0003892, EFO_0004713 | |
| Disease | urate measurement | BAZ1B ADGRV1 CUBN FAM13A ALDH16A1 SBF2 LRP1 RBM8A MBD5 CMAHP CCDC17 | 1.61e-03 | 895 | 126 | 11 | EFO_0004531 |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.71e-03 | 200 | 126 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | metabolic syndrome | 1.71e-03 | 200 | 126 | 5 | EFO_0000195 | |
| Disease | chronic lymphocytic leukemia | 1.72e-03 | 119 | 126 | 4 | EFO_0000095 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 1.79e-03 | 56 | 126 | 3 | EFO_0022279 | |
| Disease | Withdrawal Symptoms | 1.98e-03 | 58 | 126 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.98e-03 | 58 | 126 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.98e-03 | 58 | 126 | 3 | C0038587 | |
| Disease | Neuralgia, Supraorbital | 2.09e-03 | 16 | 126 | 2 | C0038870 | |
| Disease | Neuralgia | 2.09e-03 | 16 | 126 | 2 | C0027796 | |
| Disease | Diabetic Angiopathies | 2.09e-03 | 16 | 126 | 2 | C0011875 | |
| Disease | Neuralgia, Atypical | 2.09e-03 | 16 | 126 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 2.09e-03 | 16 | 126 | 2 | C0234249 | |
| Disease | Microangiopathy, Diabetic | 2.09e-03 | 16 | 126 | 2 | C0025945 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.09e-03 | 16 | 126 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.09e-03 | 16 | 126 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 2.09e-03 | 16 | 126 | 2 | C0751373 | |
| Disease | Nerve Pain | 2.09e-03 | 16 | 126 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.09e-03 | 16 | 126 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 2.09e-03 | 16 | 126 | 2 | C0042656 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.10e-03 | 307 | 126 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.18e-03 | 60 | 126 | 3 | EFO_0022233 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.25e-03 | 128 | 126 | 4 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.25e-03 | 128 | 126 | 4 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.25e-03 | 128 | 126 | 4 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 2.25e-03 | 128 | 126 | 4 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.25e-03 | 128 | 126 | 4 | C0007134 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 2.27e-03 | 312 | 126 | 6 | EFO_0004612, EFO_0010351 | |
| Disease | Van Buchem disease | 2.36e-03 | 17 | 126 | 2 | C0432272 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.38e-03 | 315 | 126 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | free cholesterol in very large HDL measurement | 2.39e-03 | 62 | 126 | 3 | EFO_0022273 | |
| Disease | sphingosine 1-phosphate measurement | 2.65e-03 | 18 | 126 | 2 | EFO_0800185 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.80e-03 | 224 | 126 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.85e-03 | 225 | 126 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | cerebral infarction (is_marker_for) | 2.95e-03 | 19 | 126 | 2 | DOID:3526 (is_marker_for) | |
| Disease | Alopecia | 2.95e-03 | 19 | 126 | 2 | C0002170 | |
| Disease | triglycerides to phosphoglycerides ratio | 3.11e-03 | 68 | 126 | 3 | EFO_0022327 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.24e-03 | 69 | 126 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | periodontitis (biomarker_via_orthology) | 3.60e-03 | 21 | 126 | 2 | DOID:824 (biomarker_via_orthology) | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 3.60e-03 | 21 | 126 | 2 | EFO_0022262 | |
| Disease | triglyceride measurement, phospholipid measurement | 3.61e-03 | 146 | 126 | 4 | EFO_0004530, EFO_0004639 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.69e-03 | 239 | 126 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | osteoporosis | 3.80e-03 | 73 | 126 | 3 | EFO_0003882 | |
| Disease | Lewy Body Disease | 3.95e-03 | 22 | 126 | 2 | C0752347 | |
| Disease | osteoporosis (biomarker_via_orthology) | 3.95e-03 | 22 | 126 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | serum albumin measurement | 3.98e-03 | 592 | 126 | 8 | EFO_0004535 | |
| Disease | alkaline phosphatase measurement | ACACB BAZ1B TSC2 APOB KIAA1614 ITPKB SLC12A5 PHKB CATSPER2 N4BP2L2 CMAHP | 4.22e-03 | 1015 | 126 | 11 | EFO_0004533 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RVEPTGLGVQAWASV | 756 | Q8N944 | |
| PGVLGQIWQLQVEAS | 261 | Q96LX7 | |
| GVADGLANLNPVTWV | 616 | O71037 | |
| GVADGLANLNPVTWV | 616 | Q902F8 | |
| GVPEAIGRWNVFKQQ | 131 | Q6ZQR2 | |
| PEVVVLVGVTGQSVW | 191 | Q96P56 | |
| VWKITVPEGAGIQVQ | 1966 | Q7Z407 | |
| TGQTVLVVGGVQWLN | 851 | A4D0V7 | |
| QVGTVWINAHGLRDP | 446 | Q8IZ83 | |
| ALRAGTGENAPWVVE | 261 | Q9UIG0 | |
| AFWGNVEVGRDVTVP | 106 | P22570 | |
| NRIAQWLEVVPEQGI | 166 | A8K2U0 | |
| SLGQVAVEWRVVGGT | 2616 | Q8WXG9 | |
| VIRTFPGRGNVTVNW | 2726 | Q8WXG9 | |
| PGRGNVTVNWKIIGQ | 2731 | Q8WXG9 | |
| LLGEIQVNWETVGPN | 4546 | Q8WXG9 | |
| VIQARTPFSVGWQAV | 631 | Q8IWV2 | |
| SIANTWVGAVVGAIP | 281 | Q12887 | |
| AVASWSRVQGIGIPL | 186 | P25101 | |
| VTRVVGGEEARPNSW | 26 | P08217 | |
| RQAEVIKGSWQPVGD | 2951 | P11532 | |
| TGNATVGRVPVDDVW | 166 | Q6Q4G3 | |
| VATQVGIEWNLSPVG | 56 | P24311 | |
| TIWGLETGQVLGRVN | 146 | P61962 | |
| VGELVWGQVIATIPT | 1046 | Q16720 | |
| LWGAVVGAQNITARI | 16 | Q15109 | |
| NVTLQIWDIGGQTIG | 61 | P51157 | |
| PQRSVEGWILFVTGV | 66 | Q9Y5S9 | |
| NRLWVGTGNGVIISI | 1156 | O60271 | |
| APWAQTVVTGRARLG | 2076 | O00763 | |
| RINVGWNGIEPSATA | 681 | O95170 | |
| PVVVWEKGGQQLAAS | 41 | O75147 | |
| AVVQAIVRTAGGWAA | 541 | A6NGU5 | |
| IPVQVDGEAWIQRPG | 1006 | Q5KSL6 | |
| QVEGRGLEQAGWILT | 216 | P04629 | |
| GVGLVRTVEWGQLPA | 241 | A6NCF5 | |
| GAVPLIQSRIVGGWE | 16 | P20151 | |
| VQVEVNGVPRWGSVC | 436 | Q96JB6 | |
| QRITGGEQVLWGPIT | 81 | P43364 | |
| RLWVGTGNGVVISIP | 1156 | Q9UPT6 | |
| GINRVRVSWLGEEPV | 151 | Q9BQ67 | |
| GTIVEERVNRPGWNE | 1066 | Q86WG5 | |
| VRQAPGKGLEWVANI | 56 | P01780 | |
| TNGIGRVEGIAVDWI | 1961 | Q07954 | |
| QEWRIGGNTIQGVTI | 1041 | Q5SZK8 | |
| GQERRVLVNASLGWP | 491 | O75197 | |
| IQRPGDLVWINAGTV | 1211 | O15550 | |
| QRPGDLVWINAGTVH | 1456 | O15054 | |
| RVWGVQLQGPSVLES | 71 | Q5VZ46 | |
| ALAWAQREGQGPAVT | 576 | O43593 | |
| SPGRDINVTGVWERN | 161 | Q16549 | |
| NEGIPWTKVTIRGEN | 16 | Q96KP1 | |
| GVLRQIPVVGSVLNW | 636 | Q6P996 | |
| QGFIVNGRVWEEPVL | 1601 | Q5H8C1 | |
| NAQGQVIGTLPWVVN | 11 | Q14863 | |
| RVVLVNTSLGWPNGL | 481 | O75581 | |
| VQGRPQPEVTWRING | 356 | P32004 | |
| AVVQAIVRTAGGWAA | 191 | Q14390 | |
| LQAVWRGPAGLVTQL | 46 | E5RJM6 | |
| EAVTRAKQIVWNGPV | 326 | P00558 | |
| VAAGIWLVEPGEAAQ | 326 | Q96S07 | |
| QGLTENGIPAVVWNI | 51 | O94988 | |
| GVADGLANLNPVTWV | 1376 | P63135 | |
| RVPVIVQVHGGFSQW | 4521 | Q96RW7 | |
| VRWETQQPECGGILT | 581 | O60494 | |
| WVNGQVPDGVSKVLV | 721 | P04114 | |
| IQWEERNVTAIQGPG | 61 | P50213 | |
| GVADGLANLNPVTWV | 616 | P61570 | |
| GVADGLANLNPVTWV | 616 | Q69384 | |
| TPNKGVWVNGLRVDL | 5306 | Q9Y6R7 | |
| IVTITWGGQNIGRSP | 551 | P21333 | |
| WTAEGRVVGVTQPRR | 96 | Q9H5Z1 | |
| GGAVLQLRPNDQVWV | 661 | P25067 | |
| VQAPLSQQRWVGGSV | 26 | P35613 | |
| VPQTTQGFIGWRSAV | 91 | Q9H1P6 | |
| GAWRVTLVQQAAAGP | 141 | P10075 | |
| VGWQAVATVPEILNG | 641 | Q9UQ52 | |
| AGVIGVELGSVWQRL | 221 | P09622 | |
| VPVGWQRRVDQNGVL | 21 | Q9P267 | |
| QVDVWGAQAGLVVAG | 66 | Q9Y3B6 | |
| SQAWREEVAAPGAVG | 766 | Q6ZRV2 | |
| NPAVPWGQGIDIQRA | 326 | P42261 | |
| NGSVPIWITAQRQGL | 121 | Q6UWV6 | |
| WALVQAGIRDGVVRP | 1811 | P49327 | |
| QWQPVNTGRGIAFSI | 886 | Q6ZTR5 | |
| EVPVTRLQEQGLQGW | 36 | Q8TEY5 | |
| WQILERTPNGIIVAG | 946 | Q93100 | |
| LRQSIVGAEVGVWTG | 416 | Q9UKN5 | |
| VDNRVVGQTGWGQVA | 336 | Q6P5Z2 | |
| EAVNGNLVVGTLAWP | 491 | Q9H2X9 | |
| NVAIWALASVVGVPV | 171 | P41146 | |
| WTPVQVFVLAQGLGV | 276 | P41146 | |
| LVGANGIWGQRAVDI | 101 | P21549 | |
| VQLVGQSPGEGRWQE | 246 | Q9BZE2 | |
| GDRVGVQPGNSRVWQ | 496 | P27987 | |
| GQIVVQSSAWERPGA | 2611 | Q6ZNJ1 | |
| EVQRGQFQGRPVSVW | 2646 | P58107 | |
| EVQRGQFQGRPVSVW | 3711 | P58107 | |
| VQRGQFQGRPVSVWD | 4246 | P58107 | |
| TVQVSWLALIQRGGG | 111 | Q8TEB7 | |
| EIVQGVLQQGTAWRR | 56 | Q92185 | |
| VSILWIPVVQASQGG | 431 | Q8WWX8 | |
| QNNLPAVRWVGGPEI | 316 | P48643 | |
| WGELVQLDPQTVGVI | 536 | O00267 | |
| WGTTQDGQTRPRVVK | 411 | Q9Y6Y8 | |
| AVPGQANEIVLIEWG | 271 | P47972 | |
| VGATKVPRNQDWLGV | 21 | P40967 | |
| VLPDGQVIWVNNTII | 96 | P40967 | |
| VVQVIRQRNWVVVGG | 76 | Q96A35 | |
| EAVQGGWQLLQTRVV | 721 | Q9NRC6 | |
| LRSIGQAVQPWVEAV | 136 | P0CW24 | |
| RQTWGAEGRVQGALV | 136 | Q6UX72 | |
| GVQLTNINVVPFGIW | 131 | Q9Y471 | |
| PGFRITVVTWNVGTA | 421 | Q15735 | |
| AVIQSVPGFWANVIA | 156 | A0A494C1R9 | |
| QLTRVAVDVGAGPWG | 426 | Q9H3T3 | |
| VVNPWIIIGGVATVV | 216 | Q99611 | |
| AVIQSVPGFWANVIA | 156 | P0CV99 | |
| LVVEGGPNVILSVWE | 291 | Q9BX84 | |
| VSVAWLPVVQAAQGG | 436 | P31639 | |
| EAWLLPAVGREVAQG | 101 | Q6SZW1 | |
| PAAGNTWRTVADGVQ | 596 | Q96MS0 | |
| PWRGQQGLAEVAVRL | 661 | Q96MS0 | |
| LQVIKGNGRTSPWEI | 31 | Q96BH1 | |
| PAVSAVWGQCQVRIR | 201 | Q99619 | |
| AETRQPVVILLGWGG | 31 | Q6P2H8 | |
| WIRGSNPQDKRQVGI | 416 | Q8TBZ2 | |
| DSIQVGGRISPQTVW | 1241 | Q92576 | |
| RNGVLWAQGPLETVT | 746 | Q9BZZ2 | |
| AVNVQVWPGATVREG | 1086 | Q9BZZ2 | |
| VWPGATVREGQLVNL | 1091 | Q9BZZ2 | |
| PWLPVNVTQGGARQE | 781 | Q9P283 | |
| RQGSQGWEVLDPAVA | 661 | Q9P2J2 | |
| VATVEAVQGRPGGTW | 1616 | Q96JG9 | |
| GVSVGQRWQDVLPVA | 306 | Q5R3I4 | |
| VAGALVVALWGPLQD | 166 | Q9H1Z9 | |
| AEAVQLQRVVGPDWT | 261 | Q8WVZ1 | |
| WVGDVVVPCTQASQR | 751 | Q5SXM2 | |
| ATQQWLGGQRGVRVP | 1281 | Q5SXM2 | |
| GTTQIDPNWVIRHQG | 971 | P35442 | |
| NGVVVTWNLGRPSRN | 96 | Q96S15 | |
| VNRVPAGNWVLIEGV | 541 | Q15029 | |
| RGETRQWQTAVIIGP | 361 | Q9Y462 | |
| TVLPGELQSWVRGQR | 96 | O95125 | |
| WRGNGTNVIKIAPET | 251 | Q6NUK1 | |
| TIGIAPWGVIENRND | 201 | Q96QT4 | |
| QVTQAPGGWEVLAVV | 261 | Q06418 | |
| TQGWAEILVRRPTGN | 1191 | P49815 | |
| GNDWVPVTIIDVRGH | 51 | Q92802 | |
| PGGPRRWVTVQVQGQ | 126 | P28698 |